《大行報告》大摩下調互太紡織(01382.HK)目標價至3.55元 評級「與大市同步」
大摩發表評級報告指,互太紡織(01382.HK)2022財年下半年純利爲2.25億元,低於該行及市場預期,主要因毛利率下降;管理層料2023財年收入爲60億元,按年持平,並估計平均售價增10%及銷量跌10%,監於日本客戶逐步恢復,該行認爲公司對2023年下半年的預期較爲保守。
大摩表示,公司明年純利目標爲5.5至6億元,按年持平,考慮到材料成本見頂,其利潤率假設也顯得保守;該行將公司明年及2024年收入預測下調7%及8%,主要受終端市場前景不確定性。目標價由4.15元下調3.55元,維持其評級爲「與大市同步」。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.